Company Performance: Novo Nordisk's financial results, including revenue, profit margins, and earnings per share significantly impact the stock price.

Pharmaceutical Pipeline: Progress in research and development, clinical trial outcomes, and potential new drug approvals drive investor sentiment.

Market Sentiment: General investor confidence, economic conditions, and industry trends (like the growing demand for diabetes and obesity treatments) influence demand.

Competition: Activities of rival pharmaceutical companies and the availability of alternative treatments affect market share and profitability.

Regulatory Changes: Government regulations, drug pricing policies, and healthcare reforms can impact Novo Nordisk's revenue and profitability.

Economic Factors: Interest rates, inflation, and currency exchange rates, particularly the Danish Krone (DKK) against the Euro, affect international operations and investor returns.

Global Health Trends: Prevalence of diabetes, obesity, and other metabolic disorders influence the demand for Novo Nordisk's products.

Supply Chain: Disruptions or efficiencies in the production and distribution of Novo Nordisk's products can affect availability and stock performance.

Investor News: Major news events, company announcements, and analyst ratings affect investor perception and trading activity.

Geopolitical Risk: Global political instability or trade tensions could impact Novo Nordisk's international operations.